2026-03-19 Synektik shareholders have unanimously approved the division of the company and spinoff of the cardiotracer project to Syn2bio Corporate news Investor relations
2025-11-17 Synektik edges closer to demerger as Syn2bio files prospectus with KNF Corporate news Investor relations